UTHSC In the Media


Exploring the Use of Stem Cells in Fat to Repair Damage From Diabetic Retinopathy

In the Media Icon

an assistant professor at the University of Tennessee Health Science Center in Memphis, Gangaraju has relocated from Indiana School of Medicine—along with a $1-million grant from the National Eye Institute—to continue his quest to halt the damage that diabetes causes. His method? Repair the damage with stem cells, using a plentiful source: fat tissue.


Mid-South Memories: Nov. 16, 1979

The Commercial Appeal

Dave Darnell/The Commercial Appeal files Dr. William G. Andrade (right), director of the Emergency Services Dept. at Le Bonheur Children’s Hospital, discusses new emergency room ideas to be implemented at the hospital with (from left) Francis X. Maguire, senior vice president of Corporate Communications at Federal Express (now FedEx); Dr. John Griffith, Medical Director at… Read More


Group buying up land in Edge district

The Commercial Appeal

Investments in the Medical District are planned by the University of Tennessee Health Science Center, Methodist Le Bonheur Healthcare and St. Jude Children’s Research Hospital, but many blocks remain unsightly, Prosterman said.


Methodist Caps Busy 2015 With $40M Plans for Transplant Institute

The Daily News

When the health care system announced the $40 million gift a week ago, it said the money would be used to transform the current Methodist University Hospital Transplant Institute, which is a partnership between Methodist and the University of Tennessee Health Science Center.


West Cancer Center Celebrates Grand Opening

In the Media Icon

The Grand Opening is a result of an innovative partnership between Methodist Healthcare, the University of Tennessee Health Science Center, and West Clinic, who joined together in January 2012 to form West Cancer Center.


Largest donation ever catalyzes Transplant institute

The Memphis Business Journal

Methodist Le Bonheur Healthcare (MLH) and the University of Tennessee Health Science Center (UTHSC) have received the largest gift in their 100-year history.


Le Bonheur to test promising new drug on babies battling RSV

The Commercial Appeal

Le Bonheur is the “main place” for the worldwide test of a antiviral drug known as ALS-008176, which could redefine how RSV cases are handled, said Dr. John DeVincenzo, medical director, molecular and viral diagnostics at Le Bonheur. He’s the lead author of a study — published last week in the New England Journal of… Read More


Anticoagulant Reversal Agents Widen AF Treatment Options

In the Media Icon

“Reversal agents for new “Reversal agents for new anticoagulants are important because anticoagulation is still underused as stroke prevention in patients with atrial fibrillation,” said panel member Prof. Lisa Jennings, PhD, director of the vascular biology center at the University of Tennessee Health Science Center (UTHSC; Memphis, USA). are important because anticoagulation is still underused… Read More